Ignite Creation Date:
2025-12-25 @ 12:46 AM
Ignite Modification Date:
2025-12-25 @ 10:59 PM
Study NCT ID:
NCT01242267
Status:
COMPLETED
Last Update Posted:
2023-01-03
First Post:
2010-11-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT
Sponsor:
Hackensack Meridian Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-05-11
Start Date Type:
ACTUAL
Primary Completion Date:
2016-01-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01-20
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-15
First Submit QC Date:
None
Study First Post Date:
2010-11-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-25
Results First Submit QC Date:
None
Results First Post Date:
2023-01-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-16
Last Update Post Date:
2023-01-03
Last Update Post Date Type:
ACTUAL